Mount Sinai Wins $20.7 Million Deal to Build a Next-Generation Respiratory Vaccine Platform
Mount Sinai researchers have received a five-year, $20.7 million agreement to develop the VITAL vaccine platform, beginning with an intranasal ...
Tag: RAVEN program
POPULAR NEWS
-
Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone
-
Endurance Exercise Reshapes the Liver in Males and Females Through Distinct Molecular Routes
-
Single Transcription Factor PU.1 Rapidly Converts Fibroblasts into Macrophage-Lineage Cells
-
New Scale Measures How Ready Nurse Educators Really Are for the AI Era